Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Phase III study of Pomalidomide and low dose Dex with or without Pembrolizumab (MK3475) in MM
Clinical Trial Grant
Duke Scholars
Principal Investigator
Cristina Gasparetto
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Merck Sharp & Dohme
Start Date
May 1, 2016
End Date
April 30, 2021
Awarded By
Merck Sharp & Dohme
Start Date
May 1, 2016
End Date
April 30, 2021
